Published in Diabetologia on January 01, 1987
Urinary C-peptide measurement as a marker of nutritional status in macaques. PLoS One (2011) 1.03
Should A1C targets be individualized for all people with diabetes? Arguments for and against. Diabetes Care (2011) 0.91
Galactose promotes fat mobilization in obese lactating and nonlactating women. Am J Clin Nutr (2010) 0.89
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes? Diabetes Obes Metab (2015) 0.87
Urinary C-peptide of insulin as a non-invasive marker of nutritional status: some practicalities. PLoS One (2011) 0.85
Urinary C-peptide excretion: a novel alternate measure of insulin sensitivity in physiological conditions. Obesity (Silver Spring) (2010) 0.84
Disorders of glucose metabolism: post mortem analyses in forensic cases--part II. Int J Legal Med (2010) 0.81
Relationship between whole-body macronutrient oxidative partitioning and pancreatic insulin secretion/β-cell function in non-diabetic humans. Metabolism (2014) 0.78
The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes. Diabetologia (2014) 0.77
Investigation of the introduction of three times daily injections of Insulin Lispro Mixture-50 on an outpatient basis: therapeutic effects of 12 months' treatment with and without concomitant sulfonylurea. J Diabetes (2012) 0.77
Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD)--a study protocol for a pilot randomized controlled trial. Trials (2013) 0.75
The Need for Faster Insulin. J Diabetes Sci Technol (2016) 0.75
Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes. Expert Rev Endocrinol Metab (2015) 0.75
A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach. Diabetes Ther (2017) 0.75
Global and societal implications of the diabetes epidemic. Nature (2001) 25.18
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Local research ethics committees. BMJ (1995) 6.30
Medical errors: a common problem. BMJ (2001) 4.69
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ (1990) 3.65
Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J (1978) 3.54
Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet (2000) 3.53
Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem (1978) 2.93
Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia. Lancet (1976) 2.84
Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74
Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet (1989) 2.69
Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J (1978) 2.57
Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens (2000) 2.54
Training in academic medicine: a way forward for the new millennium. A discussion document from the Academic Medicine Committee of the Royal College of Physicians. J R Coll Physicians Lond (1999) 2.42
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41
Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36
Initial effect of injury on ketone bodies and other blood metabolites. Lancet (1975) 2.27
The management of diabetes during surgery. Br J Anaesth (1979) 2.20
Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med (1990) 2.16
Dangers of intravenous fructose. Lancet (1972) 2.15
Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg (2001) 2.13
Development and validation of a questionnaire for the assessment of physical activity in epidemiological studies in Sub-Saharan Africa. Int J Epidemiol (2001) 2.06
The pitfalls of measuring changes in smoking habits. Essential NCD Health Intervention Project Team. Trop Doct (2000) 2.03
High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology (1971) 1.86
Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J (1974) 1.82
Occupational status and cardiovascular disease risk factors in the rapidly developing, high-risk population of Mauritius. Am J Epidemiol (1998) 1.75
Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle (1990) 1.75
Insulin dependent diabetes mellitus: a lethal disease in the developing world. BMJ (1994) 1.72
Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr (1998) 1.70
Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care (1994) 1.68
Specificity of hypoglycaemia for cerebral malaria in children. Lancet (1990) 1.68
Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association. Diabet Med (1998) 1.62
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) (1982) 1.61
Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health (1997) 1.61
Impaired glucose tolerance. BMJ (1990) 1.60
Lung function in patients with diabetes mellitus. Respir Med (1990) 1.59
The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol (2001) 1.57
Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study. BMJ (2000) 1.57
The metabolic effects of sodium dichloroacetate in the starved rat. Biochem J (1974) 1.52
Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health (1997) 1.51
Diabetes mellitus: a new look at diagnostic criteria. Diabetologia (1979) 1.49
Low prevalence of risk factors for coronary heart disease in rural Tanzania. Int J Epidemiol (1993) 1.48
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax (1987) 1.48
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). Diabetes Obes Metab (2015) 1.47
Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania. BMJ (1991) 1.46
The metabolic effects of quinine in children with severe and complicated Plasmodium falciparum malaria in Dar es Salaam. Trans R Soc Trop Med Hyg (1992) 1.44
The effect of acetoacetate on plasma insulin concentration. Biochem J (1971) 1.44
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes. Diabetes Res Clin Pract (2011) 1.44
Drug therapy for coronary heart disease: the Sheffield table. Lancet (1998) 1.43
Experimental diabetic ketoacidosis. Sequential changes of metabolic intermediates in blood, liver, cerebrospinal fluid and brain after acute insulin deprivation in the streptozotocin-diabetic rat. Biochem J (1974) 1.42
The UK Diabetes Dataset: a standard for information exchange. Diabetes Audit Working Group of the Research Unit of the Royal College of Physicians. British Diabetic Association. Diabet Med (1995) 1.42
Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutation. Diabetes Care (1995) 1.42
Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-dependent diabetes. Lancet (1981) 1.40
Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract (1993) 1.40
Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet (1979) 1.39
Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function. Q J Med (1994) 1.39
Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia (1977) 1.39
Letter: Metabolic effects of bran. Br Med J (1976) 1.38
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38
Insulin availability among International Diabetes Federation member associations. Report of the Task Force on Insulin Distribution. Diabetes Care (1994) 1.37
A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins. Diabet Med (1984) 1.37
Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest (1988) 1.36
Performance of blood-glucose strips. Lancet (1979) 1.34
Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33
Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur J Clin Invest (1975) 1.33
"Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet (1983) 1.33
Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Diabet Med (2006) 1.33
Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke (1999) 1.32
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed) (1981) 1.32
Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem J (1990) 1.31
A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med (1999) 1.31
Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis (1992) 1.29
Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med (2000) 1.27
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes (2001) 1.27
Outlook for survivors of childhood in sub-Saharan Africa: adult mortality in Tanzania. Adult Morbidity and Mortality Project. BMJ (1996) 1.25
Biguanides. Diabetologia (1978) 1.24
Impaired fasting glucose: how low should it go? Diabetes Care (2000) 1.24
Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem (1978) 1.24
Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health (1999) 1.24
Insulin dependent diabetes in childhood and material deprivation in northern England, 1977-86. BMJ (1991) 1.24
Diabetic coma. Clin Endocrinol Metab (1972) 1.23
The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care (1989) 1.22
Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-year-old children. Diabetologia (1997) 1.21